ARCHIVES

FDA to refer false statements by regulated companies to SEC.

This article is from The Cancer Letter archive.

Vol. 30 No. 09 | February 27, 2004

Download PDF Visit The Full Archive

Related Articles

ACS Endorses Clinton Health Care Reform, Wit qualifications

March 11, 1994

Abraxane Combination Improves Survival In Treatment-Naïve Metastatic Disease

February 22, 2013

FDA Deputy Commissioner Gottlieb To Return To AEI.

December 15, 2006

Grantees Not In Danger Of Losing Cost-Free Biological Materials, But Can’t Have Chemicals

September 9, 1977

CCIRC Members Now Feel At Home In DCT

March 3, 1978

CCRU, CCSP Projects Described; Plans Listed for DRCCA Applications Branch

November 11, 1983